{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:01:43Z","timestamp":1785348103336,"version":"3.55.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>In 2005, Finland replaced the whole-cell pertussis (wP) 3\u2009+\u20091 schedule with an acellular pertussis (aP) 2\u2009+\u20091 infant schedule supplemented by a DTaP-IPV preschool booster at age 4\u00a0in the National Immunization Program (NIP). Recent pertussis resurgence and uncertainty about the duration of vaccine-induced protection have raised concerns. We assessed the effectiveness, duration of protection and population-level impact of the preschool booster. We conducted a nationwide population-based register study in Finland (1995\u20132019). Vaccine effectiveness (VE) of a two-component (2aP) preschool booster against laboratory-confirmed pertussis was estimated by comparing children with and without the booster, followed from age of 4.25 years during 2011\u20132019 using a covariate-adjusted Cox proportional hazards model. Population-level impact was assessed by comparing pertussis incidence before (1995\u20132002; wP primary series without preschool booster) and after (2012\u20132019; aP primary series with the booster) its introduction. The primary cohort included 466 240 children (94% vaccination coverage). Among 225 cases, 88% were diagnosed serologically and 12% by culture or PCR. VE against any laboratory-confirmed pertussis during 5-year follow-up was 51% (95% CI, 27\u201367), with VE of 86% (95% CI, 67\u201394) against PCR\/culture-confirmed and 37% (95% CI, \u22121\u201360) against serology-confirmed cases. VE remained stable up to 8 years post-vaccination without clear waning. Following booster introduction in the NIP, pertussis incidence decreased by 65% (95% CI, 60\u201369) among children \u22654.25 years and by 39% (95% CI, 30\u201348) among those \u22643.75 years, indicating both direct and indirect effects. The 2aP preschool booster seems to provide moderate and sustained protection against pertussis compared to children without the booster. Effectiveness was notably higher against PCR\/culture-confirmed cases throughout the follow-up, likely due to lower specificity of serology and differences in diagnostic practices by disease manifestations. These findings support continued use of the preschool booster in Finland.<\/jats:p>","DOI":"10.1371\/journal.pgph.0006800","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:41:17Z","timestamp":1785346877000},"page":"e0006800","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and impact of the 2-component acellular pertussis vaccine as a preschool booster in Finland \u2013 A register-based study"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1366-9451","authenticated-orcid":true,"given":"Jussi A.","family":"Halme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva K.","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Rinta-Kokko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0189-4723","authenticated-orcid":true,"given":"Kimmo","family":"Niinim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Soininen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Abrudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Camilo","family":"Vargas-Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto A.","family":"Palmu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"pgph.0006800.ref001","article-title":"Infectious diseases as a cause of global childhood mortality and morbidity: Progress in recognition, prevention, and treatment","author":"L D. Frenkel","year":"2018","journal-title":"apr"},{"issue":"23","key":"pgph.0006800.ref002","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.vaccine.2021.04.032","article-title":"Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis","volume":"39","author":"K Wilkinson","year":"2021","journal-title":"Vaccine"},{"key":"pgph.0006800.ref003","unstructured":"World Health Organization. Pertussis: reported cases and incidence. https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/pertussis-reported-cases-and-incidence. Accessed 2025 August 26."},{"issue":"11","key":"pgph.0006800.ref004","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41579-024-01064-8","article-title":"Pertussis vaccines, epidemiology and evolution","volume":"22","author":"M Domenech de Cell\u00e8s","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"pgph.0006800.ref005","volume-title":"Rokottajan k\u00e4sikirja 2005","author":"H Nohynek","year":"2005"},{"key":"pgph.0006800.ref006","volume-title":"Prevention of whooping cough in Finland 2017\u20132021","author":"J Mertsola","year":"2017"},{"key":"pgph.0006800.ref007","unstructured":"Finnish Government. Whooping cough vaccine in pregnancy will be permanently added to the vaccination programme \u2013 the aim is to prevent cases of whooping cough in babies. Finnish Government. https:\/\/valtioneuvosto.fi\/en\/-\/155392151\/whooping-cough-vaccine-in-pregnancy-will-be-permanently-added-to-the-vaccination-programme-the-aim-is-to-prevent-cases-of-whooping-cough-in-babies. 2024. Accessed 2026 May 21."},{"key":"pgph.0006800.ref008","unstructured":"Finnish Institute for Health and Welfare THL. Finnish National Infectious Diseases Register, statistical database \u2013 cases. Finnish Institute for Health and Welfare. https:\/\/sampo.thl.fi\/pivot\/prod\/en\/ttr\/cases\/fact_ttr_cases?&row=nidrreportgroup-878285&column=yearmonth-878344. 2025. Accessed 2025 October 6."},{"issue":"9","key":"pgph.0006800.ref009","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/14760584.2022.2084076","article-title":"A combined DTaP-IPV vaccine (Tetraxim\u00ae\/Tetravac\u00ae) used as school-entry booster: A review of more than 20 years of clinical and post-marketing experience","volume":"21","author":"C Huoi","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"pgph.0006800.ref010","unstructured":"World Health Organization WH. Diphtheria tetanus toxoid and pertussis (DTP) vaccination coverage. https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/diphtheria-tetanus-toxoid-and-pertussis-(dtp)-vaccination-coverage. Accessed 2025 October 16."},{"key":"pgph.0006800.ref011","unstructured":"Finnish Institute for Health and Welfare THL. Rokotuskattavuus. THL. https:\/\/www.thl.fi\/roko\/vaccreg\/atlas\/public\/atlas.html?show=infantbc&indicator=DTaP-IPV1&date=2015%20syntyneet%20lapset&prop_legendClassifier=customClassifier&pal_defaultPaletteId=Diverging%20Purple%20to%20Green&pal_defaultSchemeId=categoricScheme1&pal_noClasses=5&bbox=-254439.54297681537%2C6579829.487000001%2C1072082.0229768152%2C7838274.432999999. 2025. Accessed 2025 October 16."},{"issue":"5","key":"pgph.0006800.ref012","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3402\/ijch.v66i5.18310","article-title":"National immunization program in Finland","volume":"66","author":"S Rapola","year":"2007","journal-title":"Int J Circumpolar Health"},{"key":"pgph.0006800.ref013","unstructured":"HUSLAB. The Bordetella pertussis antibodies (2471 S-BopeAb) test method and reference values will change starting February 10, 2016. https:\/\/huslab.fi\/ohjekirjan_liitteet\/tutkimustiedotteet\/tutkimustiedotteet_2016\/2016_08_tutkimuksen_bordetella_pertussis_vasta_aineet_menetelma_ja_viitearvot_muuttuvat_10_02_2016_alkaen.pdf. 2016. Accessed 2025 May 7."},{"issue":"3","key":"pgph.0006800.ref014","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","article-title":"What to do and what not to do in serological diagnosis of pertussis: Recommendations from EU reference laboratories","volume":"30","author":"N Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"pgph.0006800.ref015","volume-title":"R Core Team. R: a language and environment for statistical computing","year":"2021"},{"key":"pgph.0006800.ref016","unstructured":"Official Statistics of Finland. Births. Official Statistics of Finland. https:\/\/www.stat.fi\/en\/statistics\/synt. Accessed 2025 September 2."},{"issue":"4","key":"pgph.0006800.ref017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1198\/000313006X152649","article-title":"The difference between \u201csignificant\u201d and \u201cnot significant\u201d is not itself statistically significant","volume":"60","author":"A Gelman","year":"2012","journal-title":"Am Stat"},{"issue":"9","key":"pgph.0006800.ref018","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cid\/ciw051","article-title":"Protective effect of contemporary pertussis vaccines: A systematic review and meta-analysis","volume":"62","author":"TR Fulton","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pgph.0006800.ref019","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000000654","article-title":"Effectiveness of routine and booster pertussis vaccination in children and adolescents, federal state of Brandenburg, Germany, 2002-2012","volume":"34","author":"S Haller","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"pgph.0006800.ref020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cid\/ciz821","article-title":"Effectiveness of acellular pertussis vaccine in older adults: Nested matched case-control study","volume":"71","author":"BC Liu","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"pgph.0006800.ref021","doi-asserted-by":"crossref","DOI":"10.1542\/peds.108.5.e81","article-title":"Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: The Italian experience","volume":"108","author":"S Salmaso","year":"2001","journal-title":"Pediatrics"},{"issue":"19","key":"pgph.0006800.ref022","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.vaccine.2019.02.047","article-title":"Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009\u22122015","volume":"37","author":"NS Crowcroft","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"pgph.0006800.ref023","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/cid\/ciaa518","article-title":"A call for caution in use of pertussis vaccine effectiveness studies to estimate waning immunity: A Canadian immunization research network study","volume":"73","author":"NS Crowcroft","year":"2021","journal-title":"Clin Infect Dis"},{"key":"pgph.0006800.ref024","volume-title":"The National Immunisation Programme in the Netherlands: Surveillance and Developments in 2023\u20132024","author":"DLL Adriaansens","year":"2024"},{"issue":"2","key":"pgph.0006800.ref025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1542\/peds.2014-1729","article-title":"Duration of pertussis immunity after DTaP immunization: A meta-analysis","volume":"135","author":"A McGirr","year":"2015","journal-title":"Pediatrics"},{"issue":"6","key":"pgph.0006800.ref026","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamapediatrics.2019.0711","article-title":"Duration of immunity and effectiveness of diphtheria-tetanus-acellular pertussis vaccines in Children","volume":"173","author":"M Domenech de Cell\u00e8s","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"6006","key":"pgph.0006800.ref027","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.1194134","article-title":"Contact network structure explains the changing epidemiology of pertussis","volume":"330","author":"P Rohani","year":"2010","journal-title":"Science"},{"key":"pgph.0006800.ref028","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1099\/jmm.0.020826-0","article-title":"Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine","volume":"59","author":"T Dalby","year":"2010","journal-title":"J Med Microbiol"},{"issue":"45","key":"pgph.0006800.ref029","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1016\/j.vaccine.2014.08.069","article-title":"Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age","volume":"32","author":"A Aase","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"pgph.0006800.ref030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/INF.0b013e318161a2b9","article-title":"Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands","volume":"27","author":"SC de Greeff","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"9200","key":"pgph.0006800.ref031","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(99)04482-7","article-title":"Impact of immunisation on pertussis transmission in England and Wales","volume":"355","author":"P Rohani","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"pgph.0006800.ref032","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1323795111","article-title":"Epidemiological evidence for herd immunity induced by acellular pertussis vaccines","volume":"111","author":"M Domenech de Cell\u00e8s","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pgph.0006800.ref033","unstructured":"European Centre for Disease Prevention and Control ECDC. Increase in pertussis cases in the EU-EEA, May 2024. Stockholm (SE): ECDC. 2024. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Increase%20in%20pertussis%20cases%20in%20the%20EU-EEA%20-%20May%202024%20FINAL.pdf"},{"issue":"49","key":"pgph.0006800.ref034","doi-asserted-by":"crossref","first-page":"2400765","DOI":"10.2807\/1560-7917.ES.2024.29.49.2400765","article-title":"Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024","volume":"29","author":"M Miettinen","year":"2024","journal-title":"Euro Surveill"},{"key":"pgph.0006800.ref035","unstructured":"European Centre for Disease Prevention and Control. Vaccine Schedule Tool: By Disease. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedCountryIdByDisease=-1&SelectedDiseaseId=3&utm_. Accessed 2025 November 16."},{"key":"pgph.0006800.ref036","unstructured":"Dutch National Institute for Public Health and the Environment (RIVM). Changes in childhood vaccination schedule for 2025. RIVM. https:\/\/www.rivm.nl\/en\/news\/changes-in-childhood-vaccination-schedule-for-2025. 2025. Accessed 2025 November 14."},{"key":"pgph.0006800.ref037","volume-title":"Guidance and protocol for the serological diagnosis of human infection with Bordetella pertussis","author":"M Riffelmann","year":"2012"},{"issue":"5","key":"pgph.0006800.ref038","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/aje\/kwac015","article-title":"Identifying and alleviating bias due to differential depletion of susceptible people in postmarketing evaluations of COVID-19 vaccines","volume":"191","author":"R Kahn","year":"2022","journal-title":"Am J Epidemiol"},{"issue":"21","key":"pgph.0006800.ref039","first-page":"1991","article-title":"Clinical use of multiplex PCR virus diagnostics in respiratory infections","volume":"133","author":"M Waris","year":"2017","journal-title":"Duodecim"},{"issue":"23","key":"pgph.0006800.ref040","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.vaccine.2022.04.038","article-title":"Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998\u22122019","volume":"40","author":"E Sepp\u00e4l\u00e4","year":"2022","journal-title":"Vaccine"},{"issue":"3","key":"pgph.0006800.ref041","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1057\/s41271-018-0130-3","article-title":"Did two booster doses for schoolchildren change the epidemiology of pertussis in Israel?","volume":"39","author":"E Anis","year":"2018","journal-title":"J Public Health Policy"},{"issue":"4","key":"pgph.0006800.ref042","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpediatrics.2011.1093","article-title":"Early Impact of the US Tdap vaccination program on pertussis trends","volume":"166","author":"TH Skoff","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"pgph.0006800.ref043","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2011.11.065","article-title":"Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine","volume":"30","author":"JS Lavine","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"pgph.0006800.ref044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076180","article-title":"The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young","volume":"8","author":"AJ van Hoek","year":"2013","journal-title":"PLoS One"},{"key":"pgph.0006800.ref045","article-title":"Only every tenth adult gets booster vaccinated in time","volume":"79","author":"M Pihlava","year":"2024","journal-title":"Suom Laakaril"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:41:32Z","timestamp":1785346892000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006800"}},"subtitle":[],"editor":[{"given":"Katia","family":"Bruxvoort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0006800","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}